Latest News
Latest News
Part-time physician: Is it a viable career choice?
“Not only are more physicians seeking part-time roles than they were 10 years ago, but more large health care systems are also offering part time...
Latest News
Clinic responsible for misdiagnosing newborn’s meningitis, must pay millions
In a separate case, a Missouri doctor accused of incorrectly treating a woman’s embolism has been found not liable for her death.
From the Journals
Hearing aids are a ‘powerful’ tool for reducing dementia risk
“The evidence is building that hearing loss may be the most impactful modifiable risk factor for dementia in mid-life.”
Conference Coverage
Stroke scale cutoff might not be ideal guide for ordering CTA and detecting large vessel occlusions
If the goal is not to miss any LVOs, there is no NIHSS score below which these do not occur.
Conference Coverage
Teriflunomide delays MS symptoms in radiologically isolated syndrome
The data support the theory that treatment should begin early in patients with a high likelihood of developing symptomatic MS on the basis of...
From the Journals
Plasma monitoring supports earlier osimertinib treatment in lung cancer patients
More patients met progression-free survival endpoints after shorter stint on gefitinib.
Conference Coverage
Novel levodopa delivery system promises continuous dosing without surgery or pump
The experimental device is designed to deliver levodopa and carbidopa into the mouth through a micropump within a wearable retainer.
Guidelines
AHA backs screening for cognitive impairment after stroke
Cognitive impairment is common after a stroke; screening may help detect it early and allow appropriate multidisciplinary care, AHA says.
Conference Coverage
U.S. incidence, prevalence of myasthenia gravis is rising
These new estimates are “significantly higher” than those from a prior U.S. analysis from 2003.
Conference Coverage
Head-to-head comparison of migraine meds reveals top options
“To the best of our knowledge, this is the first study that simultaneously compared multiple acute migraine medications using a Big Data analysis...
Conference Coverage
Oral antiamyloid shows disease-modifying potential Phase 3 trial underway
Phase 2 data showed that use of the drug resulted in positive changes in plasma and imaging biomarkers of Alzheimer’s disease pathology.